These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29360003)

  • 1. Evolving therapies for Fuchs' endothelial dystrophy.
    Soh YQ; Peh GS; Mehta JS
    Regen Med; 2018 Jan; 13(1):97-115. PubMed ID: 29360003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fuchs endothelial corneal dystrophy and trinucleotide repeat expansion in TCF4--implications for diagnostics and therapy].
    Oziębło D; Szaflik JP; Ołdak M
    Klin Oczna; 2015; 117(3):200-3. PubMed ID: 26999947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTG18.1 repeat expansion may reduce TCF4 gene expression in corneal endothelial cells of German patients with Fuchs' dystrophy.
    Foja S; Luther M; Hoffmann K; Rupprecht A; Gruenauer-Kloevekorn C
    Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1621-1631. PubMed ID: 28608272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fuchs' endothelial dystrophy of the cornea.
    Adamis AP; Filatov V; Tripathi BJ; Tripathi RC
    Surv Ophthalmol; 1993; 38(2):149-68. PubMed ID: 8235998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCF4 Triplet Repeat Expansion and Nuclear RNA Foci in Fuchs' Endothelial Corneal Dystrophy.
    Mootha VV; Hussain I; Cunnusamy K; Graham E; Gong X; Neelam S; Xing C; Kittler R; Petroll WM
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):2003-11. PubMed ID: 25722209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trinucleotide Repeat Expansion in the Transcription Factor 4 (TCF4) Gene Leads to Widespread mRNA Splicing Changes in Fuchs' Endothelial Corneal Dystrophy.
    Wieben ED; Aleff RA; Tang X; Butz ML; Kalari KR; Highsmith EW; Jen J; Vasmatzis G; Patel SV; Maguire LJ; Baratz KH; Fautsch MP
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):343-352. PubMed ID: 28118661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of cell-based therapy combined with descemetorhexis for treating Fuchs endothelial corneal dystrophy in rabbit model.
    Okumura N; Matsumoto D; Fukui Y; Teramoto M; Imai H; Kurosawa T; Shimada T; Kruse F; Schlötzer-Schrehardt U; Kinoshita S; Koizumi N
    PLoS One; 2018; 13(1):e0191306. PubMed ID: 29338061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fuchs' dystrophy.
    Wilson SE; Bourne WM
    Cornea; 1988; 7(1):2-18. PubMed ID: 3280235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower Fractions of
    Westin IM; Viberg A; Byström B; Golovleva I
    Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. REVIEW: Current understanding of the pathogenesis of Fuchs' endothelial corneal dystrophy.
    Nanda GG; Alone DP
    Mol Vis; 2019; 25():295-310. PubMed ID: 31263352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of keratoplasty: cell-based therapy, regenerative medicine, bioengineering keratoplasty, gene therapy.
    Mehta JS; Kocaba V; Soh YQ
    Curr Opin Ophthalmol; 2019 Jul; 30(4):286-291. PubMed ID: 31045881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products and receptors in Fuchs' dystrophy corneas undergoing Descemet's stripping with endothelial keratoplasty.
    Wang Z; Handa JT; Green WR; Stark WJ; Weinberg RS; Jun AS
    Ophthalmology; 2007 Aug; 114(8):1453-60. PubMed ID: 17320180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional impact of ZEB1 mutations associated with posterior polymorphous and Fuchs' endothelial corneal dystrophies.
    Chung DW; Frausto RF; Ann LB; Jang MS; Aldave AJ
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6159-66. PubMed ID: 25190660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function-Related Protein Expression in Fuchs Endothelial Corneal Dystrophy Cells and Tissue Models.
    Thériault M; Gendron SP; Brunette I; Rochette PJ; Proulx S
    Am J Pathol; 2018 Jul; 188(7):1703-1712. PubMed ID: 29698634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cell microRNA expression in human late-onset Fuchs' dystrophy.
    Matthaei M; Hu J; Kallay L; Eberhart CG; Cursiefen C; Qian J; Lackner EM; Jun AS
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):216-25. PubMed ID: 24334445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An alpha 2 collagen VIII transgenic knock-in mouse model of Fuchs endothelial corneal dystrophy shows early endothelial cell unfolded protein response and apoptosis.
    Jun AS; Meng H; Ramanan N; Matthaei M; Chakravarti S; Bonshek R; Black GC; Grebe R; Kimos M
    Hum Mol Genet; 2012 Jan; 21(2):384-93. PubMed ID: 22002996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fuchs endothelial corneal dystrophy: an updated review.
    Altamirano F; Ortiz-Morales G; O'Connor-Cordova MA; Sancén-Herrera JP; Zavala J; Valdez-Garcia JE
    Int Ophthalmol; 2024 Feb; 44(1):61. PubMed ID: 38345780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial analysis of gene expression in the corneal endothelium of Fuchs' dystrophy.
    Gottsch JD; Bowers AL; Margulies EH; Seitzman GD; Kim SW; Saha S; Jun AS; Stark WJ; Liu SH
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):594-9. PubMed ID: 12556388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Topographical Model of Fuchs Dystrophy for Evaluation of Corneal Endothelial Cell Monolayer Formation.
    Rizwan M; Peh GS; Adnan K; Naso SL; Mendez AR; Mehta JS; Yim EK
    Adv Healthc Mater; 2016 Nov; 5(22):2896-2910. PubMed ID: 27701826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of Body Mass Index With Fuchs Endothelial Corneal Dystrophy Severity and TCF4 CTG18.1 Trinucleotide Repeat Expansion.
    Kinariwala BB; Xu TT; Baratz KH; Aleff RA; Patel SV; Maguire LJ; Fautsch MP; Wieben ED; Millen AE; Patel SP
    Cornea; 2021 Dec; 40(12):1567-1570. PubMed ID: 33782268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.